Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

804.00p
   
  • Change Today:
      65.00p
  • 52 Week High: 805.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 120.75m
  • Volume: 449,148
  • Market Cap: £970.85m
  • RiskGrade: 125
  • Beta: 1.75

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -30.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.9 n/a
Pr/Book 14.8  
Latest F'cast
Revenue 43.8% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OXB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 142.80 19.88 22.77p 54.0 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%
31-Dec-23 89.54 (188.53) (163.11)p n/a n/a n/a n/a 0.0%
31-Dec-24 128.80 (47.26) (41.75)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OXB Company Announcements

Response to press speculation 14-Jan-2026 16:49 RNS
Total Voting Rights 02-Jan-2026 07:00 RNS
Block Listing Return 02-Jan-2026 07:00 RNS

Latest OXB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

OXB Market Data

Currency UK Pounds
Share Price 804.00p
Change Today 65.00p
% Change 8.80 %
52 Week High 805.00
52 Week Low 232.50
Volume 449,148
Shares Issued 120.75m
Market Cap £970.85m
Beta 1.75
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

OXB Dividends

No dividends found

Trades for 14-Jan-2026

Time Volume / Share Price
16:47 5,367 @ 748.71p
16:38 3,000 @ 770.00p
16:36 311 @ 804.00p
16:36 3,672 @ 804.00p
16:36 501 @ 804.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page